Rejection and regulation: A tight balance

Current Opinion in Organ Transplantation

Volumn 17, Issue 1, 2012, Pages 1-7

  Ashoor, Isa F ^a   Najafian, Nader ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

allograft rejection; allograft tolerance; regulatory cells; transplantation

Indexed keywords

MUCIN;

B LYMPHOCYTE; DENDRITIC CELL; GRAFT REJECTION; HELPER CELL; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PHENOTYPE; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TFH CELL; TH17 CELL; TH9 CELL;

ANIMALS; B-LYMPHOCYTES, REGULATORY; CYTOKINES; DENDRITIC CELLS; GRAFT REJECTION; HLA-C ANTIGENS; HUMANS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856087304     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834ef52a     Document Type: Review

References (66)

1. Suthanthiran M. Transplantation tolerance: Fooling Mother Nature. Proc Natl Acad Sci U S A 1996; 93:12072-12075. (Pubitemid 26367095)
2. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172:603-606.
3. Safinia N, Afzali B, Atalar K, et al. T-cell alloimmunity and chronic allograft dysfunction. Kidney Int Suppl 2010; 78:S2-S12.
4. Heidt S, Segundo DS, Chadha R, Wood KJ. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 2010; 15:456-461.
5. Chadha R, Heidt S, Jones ND, Wood KJ. Th17: Contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation 2011; 91:939-945.
6. Hester J, Mills N, Shankar S, et al. Th17 cells in alemtuzumab-treated patients: The effect of long-term maintenance immunosuppressive therapy. Transplantation 2011; 91:744-750.
7. Kappel LW, Goldberg GL, King CG, et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009; 113:945-952.
8. Fabrega E, Lopez-Hoyos M, San Segundo D, et al. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl 2009; 15:629-633.
9. 3+ T cells in patients with acute cellular rejection after cardiac transplantation. Clin Transplant 2011; 25:E177-E186.
10. Hirota K, Duarte JH, Veldhoen M, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 2011; 12:255-263.
11. Soroosh P, Doherty TA. Th9 and allergic disease. Immunology 2009; 127:450-458.
12. Wong MT, Ye JJ, Alonso MN, et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol 2010; 88:624-631.
13. Poulin LF, Richard M, Le Moine A, et al. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation 2003; 76:572-577. (Pubitemid 37013265)
14. Boenisch O, Zhao X, Akiyoshi T, et al. Regulatory Role of Interleukin-9 in Alloimmunity (oral abstract). Am J Transplant 2011; 11:28-211.
15. King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008; 26:741-766. (Pubitemid 351600391)
16. Choi YS, Kageyama R, Eto D, et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011; 34:932-946.
17. Zhou X, Bailey-Bucktrout SL, Jeker LT, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10:1000-1007.
18. Lee YK, Mukasa R, Hatton RD, Weaver CT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 2009; 21:274-280.
19. 3+ regulatory T-cells in renal allografts: Correlation with long-term graft function and acute rejection. Clin Nephrol 2011; 75:91-100.
20. Batsford S, Dickenmann M, Durmuller U, et al. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful? Clin Nephrol 2011; 75:101-106.
21. Iwase H, Kobayashi T, Kodera Y, et al. Clinical significance of regulatory T-cellrelated gene expression in peripheral blood after renal transplantation. Transplantation 2011; 91:191-198.
22. 3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 2010; 90:540-546.
23. Semiletova NV, Shen XD, Baibakov B, Andakyan A. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells. J Heart Lung Transplant 2010; 29:335-341.
24. 3+ T cells in kidney operational tolerance transplanted individuals. Hum Immunol 2010; 71:442-450.
25. De Serres SA, Sayegh MH, Najafian N. Immunosuppressive drugs and Tregs: A critical evaluation! Clin J Am Soc Nephrol 2009; 4:1661-1669.
26. Raimondi G, Sumpter TL, Matta BM, et al. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J Immunol 2010; 184:624-636.
27. D'Addio F, Yuan X, Habicht A, et al. A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model. Transplantation 2010; 90:260-269.
28. 3+ regulatory T cells in allotransplantation. Transplantation 2010; 89:928-936.
29. Poirier N, Azimzadeh AM, Zhang T, et al. Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation. Sci Transl Med 2010; 2:17ra0.
30. Bestard O, Cassis L, Cruzado JM, et al. Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation. Transpl Int 2011; 24:451-460.
31. 3+ regulatory T cells. J Am Soc Nephrol 2006; 17:2844-2853. (Pubitemid 44484674)
32. Gurkan S, Luan Y, Dhillon N, et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010; 10:2132-2141.
33. Watanabe R, Fujimoto M, Ishiura N, et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 2007; 171:560-570. (Pubitemid 47344688)
34. Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CD1dhiCD5 phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28:639-650. (Pubitemid 351636247)
35. Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008; 118:3420-3430.
36. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120:1836-1847.
37. Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10- producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011; 186:5569-5579.
38. Ding Q, Yeung M, Camirand G, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011; 121:3645-3656.
39. Thomson AW. Tolerogenic dendritic cells: All present and correct? Am J Transplant 2010; 10:214-219.
40. Boenisch O, Sayegh MH, Najafian N. Negative T-cell costimulatory pathways: Their role in regulating alloimmune responses. Curr Opin Organ Transplant 2008; 13:373-378.
41. Li XC, Rothstein DM, Sayegh MH. Costimulatory pathways in transplantation: Challenges and new developments. Immunol Rev 2009; 229:271-293.
42. Strom TB, Koulmanda M. Recently discovered T cell subsets cannot keep their commitments. J Am Soc Nephrol 2009; 20:1677-1680.
43. 4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery. Mol Pharm 2011; 8:143-152.
44. De Serres SA, Vadivel N, Mfarrej BG, et al. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation 2011; 91:552-559.
45. Diaz JA, Booth AJ, Lu G, et al. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant 2009; 9:1773-1783.
46. Zhao X, Boenisch O, Yeung M, et al. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant 2011. doi: 10.1111/ j.1600-6143.2011.03770.x.
47. Burmester GR, Feist E, Kellner H, et al. Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: The first phase IIIb real-life study (TAMARA). Ann Rheum Dis 2011; 70:755-759.
48. Chen Y, Wood KJ. Interleukin-23 and TH17 cells in transplantation immunity: Does 23-17 equal rejection? Transplantation 2007; 84:1071-1074. (Pubitemid 350125345)
49. Xie A, Wang S, Zhang K, et al. Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection. Transplantation 2011; 91:27-34.
50. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, et al. The role of the IL23/ IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008; 8:1911-1920.
51. Boenisch O, D'Addio F, Watanabe T, et al. TIM-3: A novel regulatory molecule of alloimmune activation. J Immunol 2010; 185:5806-5819.
52. Ueno T, Habicht A, ClarksonMR, et al. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest 2008; 118:742-751. (Pubitemid 351206562)
53. Kuchroo VK, Dardalhon V, Xiao S, Anderson AC. New roles for TIM family members in immune regulation. Nat Rev Immunol 2008; 8:577-580.
54. Degauque N, Mariat C, Kenny J, et al. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest 2008; 118:735-741. (Pubitemid 351206561)
55. 4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 2009; 39:2492-2501.
56. He W, Fang Z, Wang F, et al. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009; 88:782-790.
57. Wang F, He W, Yuan J, et al. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transpl Immunol 2008; 19:12-19.
58. 8+ alloreactive T cell and prolongs survival of skin graft. Cell Immunol 2007; 250:68-74.
59. 25+ regulatory T cells. Immunobiology 2009; 214:342-349.
60. Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007; 318:1141-1143. (Pubitemid 350134897)
61. Yeung MY, McGrath M, Najafian N. The emerging role of the TIM molecules in transplantation. Am J Transplant 2011; 11:2012-2019.
62. Hu J, Wan Y. Tolerogenic dendritic cells and their potential applications. Immunology 2011; 132:307-314.
63. Hanvesakul R, Kubal C, Moore J, et al. KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation. PLoS One 2011; 6:e23631.
64. Lan Z, Ge W, Arp J, et al. Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenase. Transplantation 2010; 90: 1286-1293.
65. Ge W, Arp J, Lian D, et al. Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection. Transplantation 2010; 90:1145-1156.
66. Peng W, Ran B, Ma Y, et al. Dendritic cells transfected with PD-L1 recombinant adenovirus induces T cell suppression and long-term acceptance of allograft transplantation. Cell Immunol 2011; 271:73-77.